Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
2-AMINOPYRIMIDINE COMPOUND AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2024/099229
Kind Code:
A1
Abstract:
The present invention relates to a 2-aminopyrimidine compound as represented by general formula (I) and a pharmaceutically acceptable salt, solvate, or prodrug thereof, preparation methods therefor, and a pharmaceutical composition containing the compound, wherein R1, R2, Ar, X, Y, Z, m, and n have the meanings given in the description. The present invention further relates to a use of the compound of general formula (I) in preparation of a drug for treating and/or preventing hematological malignancies and inflammatory bowel disease.

Inventors:
ZHAO YANFANG (CN)
HOU YUNLEI (CN)
HAN LIANG (CN)
WEN JIAJIE (CN)
TONG MINGHUI (CN)
SHI XUAN (CN)
Application Number:
PCT/CN2023/129613
Publication Date:
May 16, 2024
Filing Date:
November 03, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
UNIV SHENYANG PHARMACEUTICAL (CN)
3D BIOOPTIMA (CN)
International Classes:
C07D401/12; A61K31/506; A61K31/5377; A61K31/541; A61P1/00; A61P1/04; A61P29/00; A61P35/02; C07D401/14; C07D403/12; C07D405/12; C07D413/14
Domestic Patent References:
WO2021000884A12021-01-07
Foreign References:
CN107074867A2017-08-18
CN102066338A2011-05-18
CN105939998A2016-09-14
CN101679440A2010-03-24
KR20150104748A2015-09-16
Other References:
LI, YINGXIU ET AL.: "Discovery of 4-piperazinyl-2-aminopyrimidine Derivatives as Dual Inhibitors of JAK2 and FLT3", EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, vol. 181, 7 August 2019 (2019-08-07), XP085857459, ISSN: 0223-5234, DOI: 10.1016/j.ejmech.2019.111590
Attorney, Agent or Firm:
CHINA SCIENCE PATENT & TRADEMARK AGENT LTD. (CN)
Download PDF: